12 hrs ago
Galena Biopharma: David Battles Goliath
In the war against cancer, much of the fighting is done by some of the smallest of pharmaceutical companies.
19 hrs ago
Teva Pharmaceutical Industries Ltd Now Covered by Maxim Group
The firm set a "buy" rating and a $56.00 price target on the stock. Maxim Group's target price points to a potential upside of 41.27% from the stock's previous close.
19 hrs ago
Just Released: "Teva-Kowa Pharma Co., Ltd. - Pharmaceuticals &...
Besides it provides prescription drugs , OTC drug, and generic pharmaceutical products with high quality and safety.
Mon Jun 17, 2013
Teva Strengthens Respiratory Franchise with Acquisition of MicroDose Therapeutx
With the addition of MicroDose's technologies and products, Teva is taking a significant step toward expanding its respiratory pipeline.
Moody's Lowers Teva's Outlook After Pfizer Settlement
On Friday, Moody's Investor Service reiterated its A3 rating for Teva Pharmaceutical Industries Ltd. , but lowered the outlook from "Stable" to "Negative", following the company's $1.6 billion patent infringement settlement with Pfizer Inc. and Takeda Pharmaceuticals Co.
Sat Jun 15, 2013
The Motley Fool
The Dow's Top 3 Stocks From Last Week
Keep track of the stocks that matter to you. Help yourself with the Fool's FREE and easy new watchlist service today.
Fri Jun 14, 2013
Pfizer reaches $2.15 billion settlement in patent infringement battle
Pfizer Inc. reached a $2.15 billion settlement with Teva Pharmaceutical Industries and Sun Pharmaceutical Industries in a nearly 10-year patent infringement legal battle.
Thu Jun 13, 2013
Cartoons & Contraceptives? Pitching Plan B to Teens
After the Obama administration decided to allow the contraceptive known as Plan B to be sold over the counter without restrictions, drug makers are facing questions over how to market the pill to teens - or whether they should at all.
New Market Report: Teva Pharmaceutical Industries Limited (TEVA) -...
Teva manufactures a broad portfolio of generic pharmaceuticals manufacturing more than 73 billion tablets annually.
Sun Pharma Declines After $550 Million Pfizer Settlement
Sun Pharmaceutical Industries Ltd. , India 's biggest drugmaker by market value, fell the most in two weeks in Mumbai after agreeing to pay more than five times what it had provisioned to settle patent litigation with Pfizer Inc. Sun shares declined 2.7 percent to 954 rupees as of 9:56 a.m. local time, headed for the biggest loss since May 31, ... (more)
Teva Pharmaceutical Industries Limited Victim of Product Tampering - Report
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today! Regulators in France have reported the first findings of an investigation into Teva Pharmceutical after some zopiclone sleeping pills were found in packs of the diuretic furosemide.
Wed Jun 12, 2013
Teva maximizes efficiency in minimal space
Teva Pharmaceutical Industries Ltd. is a global generic pharmaceuticals company whose 2012 sales topped $20 billion, producing 850 generic molecules with another 400 in development.
Teva Reaches Settlement Agreement with Pfizer and Nycomed Regarding...
Teva Pharmaceutical Industries Ltd. announced today that it has entered into a settlement agreement with Wyeth/Pfizer and Altana/Nycomed to resolve all claims relating to Teva's sales, commencing in December 2007, of its 20 mg and 40 mg generic Protonix tablets.
Wall St. Cheat Sheet
Aggressive Tactics Proved Too Risky For These Generic Drugmakers
Teva Pharmaceutical and Sun Pharmaceutical made a surprising decision in late 2007: sell a low-cost generic version of Protonix before the key U.S. patent expired.
Still some questions after White House's Plan B shift
Don't rush to the drugstore quite yet if you are a female under 17, need emergency contraception, and have no prescription.
Pfizer settles Protonix patent case for $2.15B
Pfizer says it has reached a $2.15 billion settlement with a couple of generic drugmakers over sales of their versions of the heartburn drug Protonix.
Tue Jun 11, 2013
Arutz Sheva Israel News
Teva Factory in France Inspected
Kol Yisrael radio reported that the French National Agency for the Safety of Medicines and Health Products completed on Tuesday an inspection of Israeli company Teva Pharmaceutical's factory in France, and did not find any organizational failure or irregularities in the manufacturing and packaging of pharmaceutical products.
SGEN Starts Adcetris Phase I/II Study - Analyst Blog
Seattle Genetics, Inc. recently commenced a phase I/II study to evaluate Adcetris in combination with Teva Pharmaceutical Industries Ltd. 's Treanda for Hodgkin lymphoma patients after first relapse.
Teva Pharmaceutical Industries Ltd Upgraded by TheStreet to Buy
The analysts wrote, "Teva Pharmaceutical Industries has been upgraded by TheStreet Ratings from hold to buy.
Opko's Frost Fights Against The Company's Large Short Interest
Dr. Phillip Frost, CEO of Opko Health Inc , appears unwilling to see a falling share price in his latest project company.